These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12241641)

  • 21. Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein.
    Oshita A; Iwai M; Chen R; Ide A; Okumura M; Fukunaga S; Yoshii T; Mogi M; Higaki J; Horiuchi M
    Hypertension; 2006 Oct; 48(4):671-6. PubMed ID: 16923992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cerivastatin on human arterial smooth muscle cell growth and extracellular matrix expression at varying glucose and low-density lipoprotein levels.
    Siegel-Axel DI; Runge H; Seipel L; Riessen R
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):422-33. PubMed ID: 12605021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors.
    Sebestjen M; Keber I; Zegura B; Simcic S; Bozic M; Fressart MM; Stegnar M
    Thromb Haemost; 2004 Nov; 92(5):1129-35. PubMed ID: 15543343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
    Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
    Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin.
    Kaneider NC; Reinisch CM; Dunzendorfer S; Meierhofer C; Djanani A; Wiedermann CJ
    Atherosclerosis; 2001 Sep; 158(1):23-33. PubMed ID: 11500171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
    Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
    Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation influences vascular remodeling through AT2 receptor expression and signaling.
    Akishita M; Horiuchi M; Yamada H; Zhang L; Shirakami G; Tamura K; Ouchi Y; Dzau VJ
    Physiol Genomics; 2000 Jan; 2(1):13-20. PubMed ID: 11015577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
    Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
    Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
    Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells.
    Brandes RP; Beer S; Ha T; Busse R
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1794-800. PubMed ID: 12933532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of monocyte chemoattractant protein-1 expression via inhibition of nuclear factor-kappaB activity in inflammatory vascular injury.
    Gao X; Iwai M; Inaba S; Tomono Y; Kanno H; Mogi M; Horiuchi M
    Am J Hypertens; 2007 Nov; 20(11):1170-5. PubMed ID: 17954363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
    Guan S; Tang Q; Liu W; Zhu R; Li B
    Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human interleukin-10 inhibits proliferation of vascular smooth muscle cells stimulated by advanced glycation end products and neointima hyperplasia after carotid injury in the rat.
    Ouyang P; Peng LS; Yang H; Peng WL; Wu WY; Xu AL
    Sheng Li Xue Bao; 2003 Apr; 55(2):128-34. PubMed ID: 12715099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.
    Kiyan J; Kusch A; Tkachuk S; Krämer J; Haller H; Dietz R; Smith G; Dumler I
    Atherosclerosis; 2007 Dec; 195(2):254-61. PubMed ID: 17275828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes.
    Corsini A; Arnaboldi L; Raiteri M; Quarato P; Faggiotto A; Paoletti R; Fumagalli R
    Pharmacol Res; 1996 Jan; 33(1):55-61. PubMed ID: 8817647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Protein Diet-Induced Fetal Growth Restriction Leads to Exaggerated Proliferative Response to Vascular Injury in Postnatal Life.
    Chisaka T; Mogi M; Nakaoka H; Kan-No H; Tsukuda K; Wang XL; Bai HY; Shan BS; Kukida M; Iwanami J; Higaki T; Ishii E; Horiuchi M
    Am J Hypertens; 2016 Jan; 29(1):54-62. PubMed ID: 26002925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.